Daiichi Sankyo’s ADC cancer drug, Enhertu, generated $3.7 billion in sales and is meeting expectations. However, challenges lie ahead for Datroway and the lead program with Merck. Despite U.S. approval for Datroway, Daiichi Sankyo faces hurdles in lung cancer development due to mixed study results and a recent setback with Merck on another ADC application. […]
Tag: AstraZeneca
AstraZeneca Pharma Reports 48% Profit Increase in Q4 FY25
AstraZeneca Pharma, a Bengaluru-based pharmaceutical company, saw a significant 48% increase in net profit to Rs 58.25 crore in the fourth quarter of fiscal year 2025. The company’s results were announced after market hours, leading to a 0.78% rise in share prices to Rs 7,980 apiece on the NSE. This positive financial performance reflects the […]
